drugset / Trial / NCT06391177

A Study to Evaluate Vonoprazan Concentrations in Breast Milk of Healthy Lactating Women Receiving Vonoprazan 20 mg Once Daily or Vonoprazan 20 mg Twice Daily

NCT06391177

Phase 1 Completed 15 enrolled Phathom Pharmaceuticals, Inc.
Non-randomizedParallel-groupOpen-labelBasic science

Summary

The primary objective is to determine the pharmacokinetics (PK) of vonoprazan in breast milk of healthy lactating women who have received vonoprazan administered once daily or vonoprazan 20 mg administered twice daily for 4 consecutive days.

Timeline

Start
2024-05-07
Primary completion
2024-09-13
Completion
2024-09-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Vonoprazan Other / unclassified 20 mg Oral